Expanded Access to Burosumab

Sponsor: Kyowa Kirin Co., Ltd.

Expanded Access
Sponsor score: 60
Inactive

ClinicalTrials ID:NCT03775187

Patient View

This program offers expanded access to Burosumab for patients lacking other treatment options, potentially available outside the US before local regulatory approval. Burosumab is a biological intervention. Eligibility criteria are not specified. For comprehensive details, refer to the provided links.

Patient Parameters

Program Overview

Individual patient expanded access requests may be considered for patients who have no other treatment options

Description

Expanded access may be available outside of the US in countries prior to approval by the local regulatory agencies. For full details, please visit the links provided below.

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Get This Program In Your Inbox

You can sign up and apply your patients for this program.